Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer.

Area of Science:

• Oncology
• Surgical Outcomes
• Body Composition Analysis

Background:

• Preoperative skeletal muscle depletion is linked to poor prognosis in non-small cell lung cancer (NSCLC).
• The impact of post-surgical skeletal muscle changes on NSCLC patient outcomes requires further investigation.

Purpose of the Study:

• To determine the relationship between changes in skeletal muscle mass after surgery and postoperative outcomes in NSCLC patients.
• To identify skeletal muscle mass changes as a prognostic factor in NSCLC.

Main Methods:

• Analysis of CT scans from 204 NSCLC patients undergoing curative resection.
• Calculation of the ratio of postoperative to preoperative skeletal muscle area (SMA) normalized to height.
• Assessment of nutritional status markers including neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, mGPS, and PNI.

Main Results:

• 34.3% of patients exhibited decreased skeletal muscle mass (SMA-decreased group).
• SMA-decreased status independently predicted poorer overall survival and disease-free survival.
• Skeletal muscle loss correlated with increased inflammation markers and poorer nutritional status post-surgery.

Conclusions:

• Postoperative skeletal muscle loss is a significant predictor of adverse outcomes in NSCLC patients.
• Further research into the benefits of postoperative nutritional interventions for NSCLC patients is warranted.